Schwartz-Arad D, Levin L, Aba M
Dept. of Oral and Maxillofacial Surgery, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
Refuat Hapeh Vehashinayim (1993). 2007 Jan;24(1):51-5, 84.
Platelet-rich plasma (PRP), made from autologous blood, is being used to deliver growth factors in high concentration to sites requiring osseous grafting. Growth factors released from the platelets include Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor Beta (TGF-b) and Insulin-Like Growth Factor 1 (IGF-1). These factors signal the local mesenchymal and epithelial cells to migrate, divide, and increase collagen and matrix synthesis. PRP has been suggested for use to increase the rate of bone deposition and quality of bone regeneration when augmenting sites prior to or in conjunction with dental implant placement. There is still lack of scientific evidence to support the use of PRP and PRF in combination with bone grafts during augmentation procedures. Further research is warranted.
富含血小板血浆(PRP)由自体血液制成,正被用于将高浓度生长因子输送到需要骨移植的部位。血小板释放的生长因子包括血小板衍生生长因子(PDGF)、转化生长因子β(TGF-β)和胰岛素样生长因子1(IGF-1)。这些因子促使局部间充质细胞和上皮细胞迁移、分裂,并增加胶原蛋白和基质的合成。有人建议在种植牙植入前或植入过程中对骨增量部位使用PRP,以提高骨沉积速率和骨再生质量。在骨增量手术中,PRP和富血小板纤维蛋白(PRF)与骨移植联合使用仍缺乏科学证据支持。有必要进行进一步研究。